Page last updated: 2024-12-07
btm 1042
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
BTM 1042: RN given refers to (cis-(-))-isomer di-HCl; 87687-13-6 is BTM 1086; 72293-40-4 is BTM 1042; 72293-46-0 is BTM 1041; 72293-22-2 is BTM 1018 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 126373 |
SCHEMBL ID | 11361489 |
MeSH ID | M0093215 |
Synonyms (13)
Synonym |
---|
btm-1042 |
btm 1042 |
72293-40-4 |
btm 1041 |
btm 1018 |
1,5-benzothiazepin-4(5h)-one, 2,3-dihydro-3-((4-methyl-1-piperazinyl)methyl)-2-phenyl-, dihydrochloride, cis-(-)- |
2,3-dihydro-3-(4-methyl-piperizinyl)methyl-2-phenyl-1,5-benzothiazepin-4(5h)-one |
cis-(-)-2,3-dihydro-3-[(4-methylpiperazinyl)methyl]-2-phenyl-1,5-benzothiazepin-4(5h)-one dihydrochloride |
YRHGKQWXSOSAQX-KJHBKDRRSA-N |
SCHEMBL11361489 |
3-[(4-methylpiperazin-1-yl)methyl]-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4-ol--hydrogen chloride (1/2) |
DTXSID30993072 |
(2r,3s)-3-[(4-methylpiperazin-1-yl)methyl]-2-phenyl-3,5-dihydro-2h-1,5-benzothiazepin-4-one;dihydrochloride |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 8 (72.73) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.85
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.85) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |